Forefront: MiR-34a-Knockout Mice with Wild Type Hematopoietic Cells, Retain Persistent Fibrosis Following Lung Injury

被引:10
作者
Bulvik, Raanan [1 ]
Biton, Moshe [2 ]
Berkman, Neville [1 ]
Breuer, Raphael [1 ,3 ]
Wallach-Dayan, Shulamit B. [1 ]
机构
[1] Hadassah Hebrew Univ, Med Ctr, Inst Pulm Med, Lung Cellular & Mol Biol Lab, POB 12000, Jerusalem 9112102, Israel
[2] Hadassah Hebrew Univ, Med Ctr, Inst Med Res Israel Canada, Lautenberg Ctr Immunol & Canc Res, Jerusalem 9112102, Israel
[3] Boston Univ, Sch Med, Dept Pathol & Lab Med, 670 Albany St,4th Floor, Boston, MA 02118 USA
关键词
miR34; FLIP; acute lung injury; cell-death; fibroblasts; myofibroblasts; fibrosis resolution; idiopathic pulmonary fibrosis; EXPRESSION; MIR-34A; MICRORNA; MYOFIBROBLASTS; APOPTOSIS; ACTIVATION; MIR-29; LIVER;
D O I
10.3390/ijms21062228
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MicroRNAs (miRs) are known to limit gene expression at the post-transcriptional level and have important roles in the pathogenesis of various conditions, including acute lung injury (ALI) and fibrotic diseases such as idiopathic pulmonary fibrosis (IPF). In this study, we found increased levels of miR-34 at times of fibrosis resolution following injury, in myofibroblasts from Bleomycin-treated mouse lungs, which correlates with susceptibility to cell death induced by immune cells. On the contrary, a substantial downregulation of miR-34 was detected at stages of evolution, when fibroblasts resist cell death. Concomitantly, we found an inverse correlation between miR-34 levels with that of the survival molecule FLICE-like inhibitory protein (FLIP) in lung myofibroblasts from humans with IPF and the experimental model. Forced upregulation of miR-34 with miR-34 mimic in human IPF fibrotic-lung myofibroblasts led to decreased cell survival through downregulation of FLIP. Using chimeric miR-34 knock-out (KO)-C57BL/6 mice with miR34KO myofibroblasts but wild-type (WT) hematopoietic cells, we found, in contrast to WT mice, increased and persistent FLIP levels with a more severe fibrosis and with no signs of resolution as detected in pathology and collagen accumulation. Moreover, a mimic of miR-34a decreased FLIP expression and susceptibility to cell death was regained in miR-34KO fibroblasts. Through this study, we show for the first time an inverse correlation between miR-34a and FLIP expression in myofibroblasts, which affects survival, and accumulation in lung fibrosis. Reprogramming fibrotic-lung myofibroblasts to regain susceptibility to cell-death by specifically increasing their miR34a and downregulating FLIP, may be a useful strategy, enabling tissue regeneration following lung injury.
引用
收藏
页数:17
相关论文
共 54 条
  • [31] miR-29 and miR-30 regulate B-Myb expression during cellular senescence
    Martineza, Ivan
    Cazalla, Demian
    Almstead, Laura L.
    Steitz, Joan A.
    DiMaio, Daniel
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (02) : 522 - 527
  • [32] Profibrotic Role of miR-154 in Pulmonary Fibrosis
    Milosevic, Jadranka
    Pandit, Kusum
    Magister, Marcus
    Rabinovich, Einat
    Ellwanger, Daniel C.
    Yu, Guoying
    Vuga, Louis J.
    Weksler, Benny
    Benos, Panayiotis V.
    Gibson, Kevin F.
    McMillan, Michael
    Kahn, Michael
    Kaminski, Naftali
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2012, 47 (06) : 879 - 887
  • [33] MicroRNA mimicry blocks pulmonary fibrosis
    Montgomery, Rusty L.
    Yu, Guoying
    Latimer, Paul A.
    Stack, Christianna
    Robinson, Kathryn
    Dalby, Christina M.
    Kaminski, Naftali
    van Rooij, Eva
    [J]. EMBO MOLECULAR MEDICINE, 2014, 6 (10) : 1347 - 1356
  • [34] Targeting Epigenetic Regulation of miR-34a for Treatment of Pancreatic Cancer by Inhibition of Pancreatic Cancer Stem Cells
    Nalls, Dara
    Tang, Su-Ni
    Rodova, Marianna
    Srivastava, Rakesh K.
    Shankar, Sharmila
    [J]. PLOS ONE, 2011, 6 (08):
  • [35] Inhibition and Role of let-7d in Idiopathic Pulmonary Fibrosis
    Pandit, Kusum V.
    Corcoran, David
    Yousef, Hanadie
    Yarlagadda, Manohar
    Tzouvelekis, Argyris
    Gibson, Kevin F.
    Konishi, Kazuhisa
    Yousem, Samuel A.
    Singh, Mandal
    Handley, Daniel
    Richards, Thomas
    Selman, Moises
    Watkins, Simon C.
    Pardo, Annie
    Ben-Yehudah, Ahmi
    Bouros, Demosthenes
    Eickelberg, Oliver
    Ray, Prabir
    Benos, Panayiotis V.
    Kaminski, Naftali
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 182 (02) : 220 - 229
  • [36] Survival in Idiopathic pulmonary fibrosis acute exacerbations: the non-steroid approach
    Papiris, Spyros A.
    Kagouridis, Konstantinos
    Kolilekas, Likurgos
    Papaioannou, Andriana I.
    Roussou, Aneza
    Triantafillidou, Christina
    Baou, Katerina
    Malagari, Katerina
    Argentos, Stylianos
    Kotanidou, Anastasia
    Karakatsani, Anna
    Manali, Effrosyni D.
    [J]. BMC PULMONARY MEDICINE, 2015, 15
  • [37] Idiopathic pulmonary fibrosis acute exacerbations: where are we now?
    Papiris, Spyros A.
    Kagouridis, Konstantinos
    Kolilekas, Likurgos
    Bouros, Demosthenes
    Manali, Effrosyni D.
    [J]. EXPERT REVIEW OF RESPIRATORY MEDICINE, 2014, 8 (03) : 271 - 273
  • [38] Identification of Keratinocyte Growth Factor as a Target of microRNA-155 in Lung Fibroblasts: Implication in Epithelial-Mesenchymal Interactions
    Pottier, Nicolas
    Maurin, Thomas
    Chevalier, Benoit
    Puissegur, Marie-Pierre
    Lebrigand, Kevin
    Robbe-Sermesant, Karine
    Bertero, Thomas
    Cardenas, Christian L. Lino
    Courcot, Elisabeth
    Rios, Geraldine
    Fourre, Sandra
    Lo-Guidice, Jean-Marc
    Marcet, Brice
    Cardinaud, Bruno
    Barbry, Pascal
    Mari, Bernard
    [J]. PLOS ONE, 2009, 4 (08):
  • [39] An Official ATS/ERSARS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
    Raghu, Ganesh
    Collard, Harold R.
    Egan, Jim J.
    Martinez, Fernando J.
    Behr, Juergen
    Brown, Kevin K.
    Colby, Thomas V.
    Cordier, Jean-Francois
    Flaherty, Kevin R.
    Lasky, Joseph A.
    Lynch, David A.
    Ryu, Jay H.
    Swigris, Jeffrey J.
    Wells, Athol U.
    Ancochea, Julio
    Bouros, Demosthenes
    Carvalho, Carlos
    Costabel, Ulrich
    Ebina, Masahito
    Hansell, David M.
    Johkoh, Takeshi
    Kim, Dong Soon
    King, Talmadge E., Jr.
    Kondoh, Yasuhiro
    Myers, Jeffrey
    Mueller, Nestor L.
    Nicholson, Andrew G.
    Richeldi, Luca
    Selman, Moises
    Dudden, Rosalind F.
    Griss, Barbara S.
    Protzko, Shandra L.
    Schuenemann, Holger J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183 (06) : 788 - 824
  • [40] Transcriptional activation of miR-34a contributes to p53-mediated apoptosis
    Raver-Shapira, Nina
    Marciano, Efi
    Meiri, Eti
    Spector, Yael
    Rosenfeld, Nitzan
    Moskovits, Neta
    Bentwich, Zvi
    Oren, Moshe
    [J]. MOLECULAR CELL, 2007, 26 (05) : 731 - 743